U.S. tribal patent deal could have big impact on generic drug market

(Reuters) – A groundbreaking deal between Allergan Plc and a Native American tribe to shield the company’s patents in administrative proceedings could also be used be to protect them from challenges in federal court, legal experts said, potentially dealing a blow to generic competition.

Leave a Reply

Read the original at Reuters: U.S..